CLIONA ROONEY to Oncolytic Virotherapy
This is a "connection" page, showing publications CLIONA ROONEY has written about Oncolytic Virotherapy.
Connection Strength
0.401
-
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patients. Mol Ther. 2015 Mar; 23(3):602-8.
Score: 0.101
-
Harnessing the immune system to potentiate oncolytics. Mol Ther. 2014 Feb; 22(2):239-240.
Score: 0.095
-
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat Med. 2013 Mar; 19(3):329-36.
Score: 0.089
-
Thunder and lightning: immunotherapy and oncolytic viruses collide. Mol Ther. 2011 Jun; 19(6):1008-16.
Score: 0.079
-
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma. Leukemia. 2020 12; 34(12):3310-3322.
Score: 0.037